Treatment may prevent Alzheimer's cognitive decline

A new study in mice found that a treatment involving antibodies to Dkk1, a protein linked to amyloid formation in Alzheimer's patients, may protect memory by stopping the disintegration of brain synapses. It won't be useful in people who already have advanced Alzheimer's disease but could potentially slow the rate of cognitive deterioration in those in the early stages of the disease.

View Full Article in:

Independent (London) (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD